Representative before the EPO

Company dna patentanwaltskanzlei dr ulrike rudolph
no operation time available
1 office
active in Legal Services

We have observed 6 EP applications Ulrike Rudolph has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 14, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12776134

PLURIPOTENT STEM CELL-DERIVED BROWN ADIPOCYTES, PLURIPOTENT STEM CELL-DERIVED CELL AGGREGATE, METHOD FOR PRODUCING SAME, AND CELL THERAPY AND MEDICAL THERAPY THEREFOR

IPC classification:
A61K 35/12, A61L 27/00, A61P 3/06, A61P 3/10, A61P 9/10, C12N 5/077, C12N 5/10, C12N 15/09
Agent:
Ulrike Rudolph, Patentanwaltskanzlei Dr. Ulrike Rudolph
Status:
GRANT OF PATENT INTENDED
EP12820708

METHOD FOR ASSESSING MYELODYSPLASTIC SYNDROME OR MYELOID TUMOR PREDISPOSITION, POLYPEPTIDE AND ANTIBODY THEREFOR, AND CANDIDATE SCREENING METHOD FOR THERAPEUTIC DRUG OR PROPHYLACTIC DRUG THEREFOR

IPC classification:
C07K 14/47, C07K 16/18, C12N 15/09, C12Q 1/68, G01N 33/15, G01N 33/50, G01N 33/68
Applicant:
University of Tokyo
Agent:
Ralf Stüven, Pohl & Partner
Agent:
Ulrike Rudolph, Patentanwaltskanzlei Dr. Ulrike Rudolph
Status:
EXAMINATION IN PROGRESS
EP12742430

HIGHLY FUNCTIONAL LIVER CELLS DERIVED FROM PLURIPOTENT STEM CELLS, METHOD FOR PRODUCING SAME, AND METHOD FOR TESTING METABOLISM/TOXICITY OF DRUG

IPC classification:
C12N 5/07, C12N 5/071, C12N 5/073, C12Q 1/02, G01N 33/50
Agent:
Ulrike Rudolph, Patentanwaltskanzlei Dr. Ulrike Rudolph
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14744750

METHOD FOR THE CREATION OF A DATABASE FOR INITIAL ASSESSMENT OF THE EFFECTIVENESS OF ACTIVE AGENTS IN TUMOUR THERAPY

IPC classification:
C12Q 1/02
Agent:
Ulrike Rudolph, Patentanwaltskanzlei Dr. Ulrike Rudolph
Status:
GRANT OF PATENT INTENDED
EP11838978

CHOCOLATE MASS

IPC classification:
A23G 1/40, A23G 1/42
Agent:
Ulrike Rudolph, Patentanwaltskanzlei Dr. Ulrike Rudolph
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12006938

Process for the separation of groups of malignant cells and groups of stroma cells from an ex vivo malignant tissue sample

IPC classification:
C12N 5/00, G01N 33/50
Agent:
Ulrike Rudolph, Patentanwaltskanzlei Dr. Ulrike Rudolph
Status:
PATENT GRANTED

Please Sign in to use this feature